Leverage has intensified with debt-to-equity reaching 12.20 in 2026Q2, as total debt of $263.7M contrasts sharply with equity of just $21.6M, signaling a strained capital structure.
Establishment Labs Holdings Inc. (ESTA) balance sheet — 10-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 |
|---|
| Total Current Assets | 247.73M | 249.94M | 243.04M | 174.9M | 149.9M | 113.27M | 132.3M | 95.84M | 99.44M | 39.38M | 12.52M |
| Cash & Short-Term Investments | 71.16M | 75.57M | 90.35M | 40.03M | 66.36M | 53.41M | 84.52M | 37.66M | 52.64M | 10.86M | 479K |
| Cash Only | 71.16M | 75.57M | 90.35M | 40.03M | 66.36M | 53.41M | 84.52M | 37.66M | 52.64M | 10.86M | 479K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 75.65M | 77.5M | 65M | 46.92M | 35.42M | 24.44M | 19.13M | 22.77M | 17.65M | 13.11M | 6.65M |
| Days Sales Outstanding | 111.98 | 134.01 | 142.9 | 103.69 | 79.96 | 70.41 | 82.45 | 92.78 | 105.24 | 137.96 | 122.55 |
| Inventory | 84.98M | 85.61M | 78.77M | 79.47M | 36.58M | 28.41M | 23.21M | 28.66M | 24.84M | 13.17M | 4.8M |
| Days Inventory Outstanding | 434.98 | 482.46 | 508.84 | 498.62 | 242.32 | 251.19 | 263.31 | 301.43 | 361.44 | 283.18 | 180.53 |
| Other Current Assets | 0 | 2.48M | 2.61M | 2.42M | 1.57M | 1.77M | 2.09M | 1.27M | 4.3M | 0 | 0 |
| Total Non-Current Assets | 104.2M | 107.23M | 103.79M | 93.74M | 61.16M | 26.26M | 24.09M | 20.69M | 17.14M | 17.71M | 17.04M |
| Property, Plant & Equipment | 74M | 79.95M | 83.59M | 80.59M | 54.79M | 20.86M | 18.81M | 16.42M | 12.91M | 13.5M | 13.23M |
| Fixed Asset Turnover | 3.14x | 2.64x | 1.99x | 2.05x | 2.95x | 6.07x | 4.50x | 5.46x | 4.74x | 2.57x | 1.50x |
| Goodwill | 1.21M | 1.21M | 1.21M | 465K | 465K | 465K | 465K | 465K | 465K | 465K | 255K |
| Intangible Assets | 9.43M | 9.94M | 11.68M | 7.99M | 4.61M | 4.37M | 4.15M | 3.44M | 3.44M | 3.4M | 2.1M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75K | 171K |
| Other Non-Current Assets | 19.56M | 16.12M | 7.31M | 4.7M | 1.29M | 558K | 664K | 368K | 315K | 347K | 1.46M |
| Total Assets | 351.93M | 357.17M | 346.83M | 268.64M | 211.06M | 139.53M | 156.39M | 116.53M | 116.57M | 57.09M | 29.56M |
| Asset Turnover | 0.70x | 0.59x | 0.48x | 0.61x | 0.77x | 0.91x | 0.54x | 0.77x | 0.53x | 0.61x | 0.67x |
| Asset Growth % | 34.92% | 2.98% | 29.11% | 27.28% | 51.27% | -10.78% | 34.2% | -0.04% | 104.17% | 93.14% | - |
| Total Current Liabilities | 64.56M | 82.14M | 68.28M | 57.15M | 38.96M | 31.89M | 25.9M | 23.24M | 16.45M | 57.44M | 54.57M |
| Accounts Payable | 32.84M | 43.11M | 44.76M | 41.62M | 20.03M | 14.47M | 9.72M | 10.37M | 6.24M | 9.13M | 7.28M |
| Days Payables Outstanding | 198.09 | 242.94 | 289.16 | 261.16 | 132.7 | 127.99 | 110.29 | 109.02 | 90.76 | 196.29 | 273.83 |
| Short-Term Debt | 0 | 12.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.09M | 39.8M |
| Deferred Revenue (Current) | 3.58M | 1.21M | 1.75M | 1.84M | 1.69M | 769K | 1.21M | 785K | 908K | 2.33M | 1.2M |
| Other Current Liabilities | 14.37M | 8.76M | 8.1M | 4.57M | 9.88M | 9.08M | 8.63M | 7.53M | 4.12M | 21.89M | 6.29M |
| Current Ratio | 3.84x | 3.04x | 3.56x | 3.06x | 3.85x | 3.55x | 5.11x | 4.12x | 6.05x | 0.69x | 0.23x |
| Quick Ratio | 2.52x | 2.00x | 2.41x | 1.67x | 2.91x | 2.66x | 4.21x | 2.89x | 4.54x | 0.46x | 0.14x |
| Cash Conversion Cycle | 348.87 | 373.53 | 362.59 | 341.16 | 189.58 | 193.6 | 235.46 | 285.19 | 375.91 | 224.85 | 29.24 |
| Total Non-Current Liabilities | 265.76M | 251.48M | 225.46M | 193.1M | 180.29M | 56.9M | 55.53M | 53.67M | 30.64M | 4.67M | 1.43M |
| Long-Term Debt | 261.7M | 247.52M | 219.58M | 188.74M | 175.46M | 51.91M | 49.83M | 48.14M | 22.32M | 0 | 0 |
| Capital Lease Obligations | 10.18M | 2.82M | 4.2M | 2.71M | 3.2M | 1.9M | 1.92M | 0 | 0 | 599K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.58M | 0 | 0 |
| Other Non-Current Liabilities | 2.09M | 0 | 554K | 147K | -44K | 703K | 1.91M | 4.19M | 7.13M | 4.07M | 1.43M |
| Total Liabilities | 330.32M | 333.62M | 293.74M | 250.25M | 219.25M | 88.79M | 81.43M | 76.92M | 47.09M | 62.11M | 56M |
| Total Debt | 263.67M | 264.47M | 225.29M | 192.22M | 179.35M | 54.21M | 52.54M | 48.4M | 22.32M | 24.09M | 38.15M |
| Net Debt | 192.52M | 188.9M | 134.95M | 152.19M | 112.99M | 793K | -31.98M | 10.74M | -30.32M | 13.22M | 37.67M |
| Debt / Equity | 12.20x | 11.23x | 4.24x | 10.45x | - | 1.07x | 0.70x | 1.22x | 0.32x | - | - |
| Debt / EBITDA | -47.54x | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -34.71x | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -0.72x | -1.30x | -3.06x | -4.11x | -5.19x | -3.38x | -3.06x | -3.31x | -1.37x | -2.34x | -5.45x |
| Total Equity | 21.61M | 23.55M | 53.09M | 18.39M | -8.19M | 50.74M | 74.96M | 39.61M | 69.48M | -5.01M | -26.43M |
| Equity Growth % | -172.36% | -55.65% | 188.64% | 324.74% | -116.13% | -32.31% | 89.23% | -42.99% | 1486.1% | 81.04% | - |
| Book Value per Share | 0.72 | 0.79 | 1.89 | 0.72 | -0.33 | 2.12 | 3.21 | 1.93 | 4.00 | -0.27 | -1.43 |
| Total Shareholders' Equity | 21.61M | 23.55M | 53.09M | 18.39M | -8.19M | 50.74M | 74.96M | 39.61M | 69.48M | -5.01M | -26.43M |
| Common Stock | 450.59M | 433.38M | 420.36M | 315.63M | 223.64M | 219.74M | 213.47M | 147.69M | 145.71M | 41.27M | 7.12M |
| Retained Earnings | -520.89M | -495.76M | -444.69M | -360.1M | -281.59M | -206.38M | -165.25M | -127.13M | -88.97M | -67.88M | -32.98M |
| Treasury Stock | -2.85M | -2.85M | -2.85M | -2.85M | -2.85M | -2.85M | -2.85M | -2.85M | -2.85M | -6.46M | -3.61M |
| Accumulated OCI | 2.16M | 1.16M | 3.29M | 1.96M | 2.71M | 3.66M | 2.87M | 691K | 449K | 76K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying ESTA stock.
As of 2025, Establishment Labs Holdings Inc. (ESTA) had total assets of $357.2M including $249.9M in current assets.
Establishment Labs Holdings Inc. (ESTA) carries total debt of $264.5M, offset by $75.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Establishment Labs Holdings Inc. (ESTA) has total shareholders' equity (book value) of $23.5M ($0.79 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Establishment Labs Holdings Inc. (ESTA) reported a current ratio of 3.04x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
High leverage and cash burn
Metrics are mathematically derived from official filings.
Leverage Rising as Losses Accumulate
Total debt climbed from $196.2M in 2024Q1 to $263.7M in 2026Q2, while equity swung from $56.9M to $21.6M, per quarterly filings, indicating a balance sheet increasingly reliant on borrowed funds.
The debt-to-equity ratio surged from 3.45 to 12.20 over the same period, reflecting both rising debt and shrinking equity as accumulated losses eroded retained earnings. This trajectory suggests the company is funding its growth through leverage rather than internal cash generation, which may heighten financial risk if revenue growth stalls or refinancing becomes costly.
Debt Burden Intensifies Amid Negative Equity
Debt-to-equity reached 12.20 in 2026Q2, up from 3.45 in 2024Q1, with total debt of $263.7M against equity of just $21.6M, as reported in the latest balance sheet.
The company's leverage is substantial, with debt representing over 75% of total assets. The high debt load, combined with negative operating cash flow, suggests that the company may face refinancing challenges or need to raise additional capital, potentially through dilutive equity issuance. The debt appears to be a necessity to fund ongoing losses and expansion, rather than a strategic choice, given the persistent negative retained earnings.
Asset Base Shifts Toward Debt-Financed Growth
Total assets grew from $301.8M in 2024Q1 to $351.9M in 2026Q2, but goodwill remains minimal at $1.2M, while PPE declined from $83.2M to $74.0M, per balance sheet data.
The modest goodwill and declining PPE suggest an asset-light model with limited acquisition activity and a potential underinvestment in fixed assets. The increase in total assets is primarily driven by higher cash and possibly receivables, but the shrinking equity base indicates that asset growth is increasingly funded by debt. This may imply that the company's tangible asset base is not expanding in line with its revenue growth, which could limit collateral for future borrowing.
Equity Eroded by Persistent Losses
Shareholders' equity fell from $56.9M in 2024Q1 to $21.6M in 2026Q2, with retained earnings deepening to -$520.9M, according to recent financial statements.
The equity base is being rapidly depleted by cumulative losses, with retained earnings becoming increasingly negative. This trend suggests that the company is not generating sufficient profits to sustain its equity, and the reliance on debt and potential future equity raises may dilute existing shareholders. The negative retained earnings also indicate that the company has not yet achieved profitability, and the equity cushion is thin, leaving little room for error.
Liquidity Buffer Thins Despite High Current Ratio
Current ratio improved to 3.84 in 2026Q2 from 4.24 in 2024Q1, but cash declined from $73.0M to $71.2M, while operating cash flow was -$16.6M, per quarterly data.
Although the current ratio remains above 3, indicating adequate short-term liquidity, the cash position is not growing and the company continues to burn cash. The high current ratio may be inflated by inventory and receivables, which could be less liquid. Given the negative operating cash flow and the need to service debt, the liquidity buffer may be insufficient to cover upcoming obligations without additional financing.
Hidden Risks in Debt and Inventory
The reported debt-to-equity of 12.20 may understate leverage if off-balance-sheet obligations exist, and inventory write-downs could further erode equity, as suggested by the complexity of implant size variations.
The balance sheet shows a high reliance on debt, but the true leverage could be higher if there are operating leases or other off-balance-sheet items not disclosed. Additionally, the company's inventory of hundreds of implant variations poses a risk of write-downs if demand shifts, which would further reduce equity. Investors should monitor inventory turnover and any undisclosed liabilities that could distort the apparent financial health.